Kura Oncology to Report Fourth Quarter and Full Year 2020 Financial Results

NEXT STORY
AREV’s Nanotech initiates early-stage antiviral photochemistry derivation discovery program for pandemic viral pathogens
PREV STORY
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aileron Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Global Ultrasound Image Analysis Software Market to Reach $1.3 Billion by 2027

author_avatar
NASDAQ Market News

Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator

author_avatar
NASDAQ Market News